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The OECD validation study of the zebrafish embryo acute toxicity test (ZFET) for acute aquatic toxicity
testing evaluated the ZFET reproducibility by testing 20 chemicals at 5 different concentrations in 3
independent runs in at least 3 laboratories. Stock solutions and test concentrations were analytically
confirmed for 11 chemicals. Newly fertilised zebrafish eggs (20/concentration and control) were exposed
for 96 h to chemicals. Four apical endpoints were recorded daily as indicators of acute lethality: coagu-
lation of the embryo, lack of somite formation, non-detachment of the tail bud from the yolk sac and lack
of heartbeat. Results (LC50 values for 48/96 h exposure) show that the ZFET is a robust method with a
good intra- and inter-laboratory reproducibility (CV < 30%) for most chemicals and laboratories. The
reproducibility was lower (CV > 30%) for some very toxic or volatile chemicals, and chemicals tested close
to their limit of solubility. The ZFET is now available as OECD Test Guideline 236.
Considering the high predictive capacity of the ZFET demonstrated by Belanger et al. (2013) in their
retrospective analysis of acute fish toxicity and fish embryo acute toxicity data, the ZFET is ready to be
considered for acute fish toxicity for regulatory purposes.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Acute fish toxicity data are part of the base set data requirements
in the hazard and environmental risk assessment of industrial
chemicals, plant protection products, biocides, pharmaceuticals
and other chemical products. Usually, fish acute toxicity is deter-
mined according to OECD test guideline (TG) 203 (OECD, 1992) or
equivalent guidelines. In brief, groups of 7–10 juvenile or adult fish
(e.g. zebrafish, fatheadminnow, Japanesemedaka, bluegill, rainbow
trout) are exposed to at least five test concentrations for 96 h, and
the concentration of the chemical that causes lethality to 50% of
the fish (LC50) is calculated. Animal welfare legislation in Europe
demands the incorporation of the 3Rs principles (replacement,
reduction, refinement) into regulatory frameworks and emphasises
the need for development and validation of alternative methods.
The relevant European Directive 2010/63/EU on the protection of
animals used for scientific purposes (EU, 2010) is a horizontal legis-
lation and therefore applicable to all EU regulatory frameworks
including tests carried out for environmental safety testing.
Possibilities of replacing, refining or reducing acute fish toxicity
tests in the regulatory framework have been discussed for many
years and have been integrated into testing strategies. For exam-
ple, REACH requires that tests on vertebrates should be minimised
and carried out only as a last resort (EC, 2006). If possible, existing
data, read across, in silico methods and/or in vitro methods should
be used to derive information on acute fish toxicity. If this is not
possible, the use of the limit test, as described in OECD TG 203,
for chemicals with predicted LC50 > 100 mg/L (OECD, 1992) or
the threshold approach according to OECD guidance document
126 (OECD, 2010) should be considered; however, both still rely
on the use of juvenile or adult fish. Other alternatives are based
on the use of fish embryos or fish cell lines. In particular, fish
embryos are considered to be the most promising alternative and
from a regulatory perspective, have already replaced the use of
juvenile/adult fish for acute toxicity testing of effluents in
Germany, where since 2005 the ‘‘zebrafish egg test’’ is required
(Anon., 2005; DIN, 2003; ISO, 2007). To encompass possible
different species sensitivities, Braunbeck et al. (2005) previously
proposed the fish embryo toxicity test ‘‘to go multi-species’’, i.e. to
adapt the protocol for zebrafish to other fish species, e.g. fathead
minnow and Japanese medaka as listed in the OECD TG 203.In 2004, the OECD included the development of a new TG ‘‘Fish
embryo toxicity (FET) test’’ for chemicals testing in its Test Guide-
line Programme with Germany as lead country. The draft FET TG
presented in 2006 proposed the use of three species (zebrafish
[Danio rerio], fathead minnow [Pimephales promelas], and Japanese
medaka [Oryzias latipes]). The draft TG specified 10 embryos per
test concentration, 48 h exposure duration, and recording of the
following endpoints as indicators for lethality: (a) coagulation of
the embryo; (b) lack of somite formation; (c) non-detachment of
the tail bud from the yolk sac; and (d) lack of heartbeat (OECD,
2006a). The OECD secretariat circulated the draft FET TG and the
supportive background document, provided by Germany
(Braunbeck and Lammer, 2006), to its member countries and asked
for feedback on the validation status of the proposed fish embryo
toxicity test method, i.e. its reliability (intra- and inter-laboratory
reproducibility) and relevance (predictive capacity, applicability
domain) for the given purpose, namely acute fish toxicity testing.
In order to tackle the many comments received, the OECD estab-
lished the ad hoc Expert Group on the Fish Embryo Toxicity Test
(AHEG FET) to discuss the draft FET TG, the submitted background
information and the comments received from the member
countries.
The experts noted that most data were available for the zebra-
fish embryo toxicity test (ZFET); however, data providing sufficient
evidence for its reproducibility were lacking and these were best
produced by carrying out a multi-laboratory ring trial. The evident
good predictive capacity was underpinned by repeated thorough
re-evaluation of existing data, which demonstrated that fish
embryo toxicity data correlated well with acute fish toxicity data
(Lammer et al., 2009). The AHEG FET further noted that the chorion
might act as a barrier for certain chemicals, e.g. for chemicals with
a high molecular weight and potential toxic effects might not be
visible (Henn and Braunbeck, 2011). It was therefore recom-
mended that the exposure duration should be extended beyond
hatch, i.e. from 48 h to 96 h.
The resulting validation work, described in the following, was
carried out between 2008 and 2012. It aimed at evaluating the
transferability, intra- and inter-laboratory reproducibility of the
zebrafish embryo acute toxicity test and the outcome of the valida-
tion formed the basis for the recently adopted OECD TG 236 ‘‘Fish
embryo acute toxicity (FET) test’’ (OECD, 2013).
Table 1
Validation management group of the zebrafish embryo toxicity validation study.
Name Affiliation Role
Marlies Halder
François Busquet
(until January
2012)
André Kleensang
(until September
2010)
European Commission, Joint Research Centre, Institute for
Health and Consumer Protection, EURL ECVAM, Ispra, Italy
Coordination/reporting
Data analysis of Phase 1a
Patric Amcoff (until
April 2011)
Anne Gourmelon
OECD Environment, Health and Safety Division, Environment
Directorate, Paris, France
OECD Test Guideline Programme
Thomas Braunbeck University of Heidelberg, Heidelberg, Germany Lead & participating laboratory; representative of German Federal
Environment Agency (Umweltbundesamt; UBA) representative (until April
2010);
Scott Belanger Procter & Gamble, Cincinnati, OH, USA Participating laboratory
Greg Carr Procter & Gamble, Cincinnati, OH, USA Data analysis for Phase 1b and Phase 2
Adam Lillicrap NIVA, Oslo, Norway Independent adviser
Susanne Walter-
Rohde
German Federal Environment Agency (Umweltbundesamt,
UBA), Dessau-Roßlau, Germany
Lead country for OECD project 2.7 (joined the VMG in April 2010)
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2.1. General conditions of the study
2.1.1. Coordination and management
In May 2008, the OECD asked the European Centre for the
Validation of Alternative Methods (ECVAM)7 to coordinate with
the support of a validation management group (VMG) the
assessment of transferability, and intra- and inter-laboratory
reproducibility of the ZFET. Following the principles for test method
validation (Balls et al., 1995; OECD, 2005), the VMG (Table 1) was
established, which was responsible for the overall design of the
study, release of the standard operating procedures (SOPs) and the
trial plans, decisions taken during the course of the study, analysis
of the results, final conclusions and reporting to OECD. The biostatis-
tical analysis was conducted by members of the VMG.
The VMG continuously kept the AHEG FET informed on the
progress of the study, and in particular, the study design and the
test chemicals were agreed upon.2.1.2. Definition of the ZFET standard operating procedure and
reporting templates
Before the start of the study, the lead laboratory provided a
draft SOP based on the draft OECD FET guideline (OECD, 2006a)
which was reviewed by the VMG. Taking into consideration the
concerns expressed by the AHEG FET, the exposure duration was
extended beyond hatch (Henn and Braunbeck, 2011), the number
of embryos per test concentration was increased for statistical
reasons from 10 to 20, and an acceptance criterion of 70% was
set for the fertility rate of the parent zebrafish used for production
of embryos (for details see OECD, 2011, 2012). A reporting
template was defined for recording lethal effects, test conditions
and other parameters per individual test run and each chemical.2.1.3. Study design
The main study was subdivided into two phases, where Phase 1
aimed to evaluate the transferability of the ZFET from the lead lab-
oratory to six laboratories by testing six chemicals. In Phase 2,
more data were generated on the intra- and inter-laboratory repro-
ducibility by testing 13 additional chemicals. Each chemical was7 Since 2010 the European Union Reference Laboratory for Alternatives to Animal
Testing (EURL ECVAM), Institute for Health and Consumer Protection, Joint Research
Centre, European Commission, Italy.tested at five different concentrations in three independent runs
in at least three laboratories. Independent runs implied that the
tests were performed with different batches of zebrafish embryos,
on different days and with test concentrations prepared for the
individual run.
For each phase, the VMG issued a trial plan describing the test
chemicals and their physicochemical properties, the preparation
of the stock solutions, test solutions, controls, data submission,
sampling and storage of stock solutions, and biostatistical analysis
(for details see OECD, 2011, 2012).
2.1.4. Participating laboratories and training
Six laboratories participated in Phase 1 and nine laboratories in
Phase 2 (Table 2). The laboratories had been recruited via a call for
expression of interest launched by the study coordinator or had
expressed their willingness to participate in the study to a member
of the VMG. The laboratories were trained in the use of the ZFET
SOP and reporting templates by testing 3,4-dichloroaniline (3,4-
DCA) in a single run as a first step and in three independent runs
as a second step (Phases 1a and 2a). The 3,4-DCA data of the
participating laboratories in Phase 1a were used to determine the
concentration of the positive control.
2.2. Materials
2.2.1. Test chemicals
Chemicals used for the validation study are shown in Table 3
and were selected based on the initial recommendations of the
AHEG FET. They cover specific areas of use (industrial chemicals,
pharmaceuticals, plant protection products, biocides), a wide range
of toxicity, physicochemical properties and various modes of
action. Two cationic polymers were included to challenge the
barrier function of the chorion. The test chemicals were aliquoted
(whenever necessary) and distributed not blinded to the laborato-
ries by the study coordinator.
2.2.2. Dilution water
Dilution water, as defined in the OECD TG 203 for acute fish tox-
icity (OECD, 1992) and with a final concentration of 294.0 mg/L
CaCl2  2H2O, 123.3 mg/L MgSO4  7H2O, 64.7 mg/L NaHCO3 and
5.7 mg/L KCl was used for the preparation of the test chemical
stock solutions, test concentrations and controls. OECD TG 203
allows a degree of total hardness equivalent to 10–250 mg/L and
requires the dilution water being aerated until oxygen saturation
Table 2
List of participating laboratories.
Laboratories Responsible
University of Heidelberg, Heidelberg, Germanya Thomas Braunbeck
Procter & Gamble, Cincinnati, OH, USAb Scott Belanger
Institute for Environmental Studies (IVM), Amsterdam, The Netherlands Juliette Legler
RIVM, Bilthoven, The Netherlands Leo van der Ven
UFZ, Leipzig, Germanyc Stefan Scholz, Melanie Knöbel
VITO, Belgiumc Hilda Witters
IPO-Pszczyna, Pszczyna, Polandb,d Przemysław Fochtman
Merck KGaA, Darmstadt, Germanyd Nicole Huebler
Umweltbundesamt, Berlin, Germanyd Carola Kussatz, Christian Polleichtner
Instituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, México City, Mexicod Fernando Martínez-Jerónimo
BASF, Ludwigshafen, Germanyd Edward Salinas
a Lead laboratory.
b Performed analytical measurements.
c Only Phase 1.
d Only Phase 2.
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ther aeration before use. The pH was adjusted to a range between
pH 6.5 and 8.5 if needed using HCl and NaOH. The conductivity of
the distilled or deionised water used for preparing the dilution
water did not exceed 10 lS/cm.
2.2.3. Controls and solvent
Dilution water served as negative control and 3,4-DCA (at 4 mg/
L) as positive control. Ethanol was used as the solvent for preparing
the triclosan stock solution, and, accordingly, a solvent control
with 0.1% ethanol was also incorporated.
2.2.4. Zebrafish breeding stocks
Laboratories used breeding stocks of unexposed, mature zebra-
fish with an age between 4 and 18 months for embryo production
via spawning groups or mass spawning; for details on maintenance
of zebrafish breeding stocks, see (Braunbeck et al., 2005; Laale,
1977; Lammer et al., 2009; Nagel, 2002; OECD, 2011, 2012, 2013;
Schulte and Nagel, 1994; Westerfield, 2000). The eleven laborato-
ries used different zebrafish strains, e.g. D. rerio wild type – family
954 (1), UFZ-OBI (1), Westaquarium (1), AB (1), Tübingen strain (1),
and own wildtype laboratory strain of unknown origin (5).
2.3. Methods
2.3.1. Stock and test solutions
Details on stock and test solution preparation are available in
the trial plans published in the validation study reports (OECD,
2011, 2012). For each chemical, five equally spaced concentrations
(see Table 3) were prepared based on the results of the range find-
ing tests carried out by the University of Heidelberg and/or Procter
& Gamble. Dilution water temperature was 26.0 ± 1.0 C when
used for preparation of test solutions and controls.
2.3.2. Preparation of glass vessels and 24-well plates
At least 24 h prior to the beginning of the test, glass vessels used
for the selection of the zebrafish eggs and 24-well plates used for
incubation were pre-saturated with freshly prepared test solutions
and respective controls. On the day of the test, glass vessels and
24-well plates were re-filled with an appropriate volume to fully
cover the eggs during the selection or 2 mL per well, respectively,
with the appropriate freshly prepared test solutions or controls.
2.3.3. Selection of embryos
In order to start exposure with minimum delay, at least twice
the number of embryos needed per test concentration or controls
were randomly selected and transferred not later than 1 h postfertilisation (hpf) into the prepared glass vessels with the test
solutions/controls. These were then placed under an inverted
microscope or a binocular microscope with a minimummagnifica-
tion of 30 to select embryos and determine the fertility rate. Only
properly developing embryos between the 4- and 128-cell stages
and an intact chorion were used (examples are given in OECD,
2013).
2.3.4. Distribution of embryos over 24-well plates
Embryos were transferred to 24-well plates (1 embryo per well)
within 3 hpf. The following distribution scheme (Fig. 1) was
applied for each run: (a) five plates with the respective test solu-
tions in 20 wells and dilution water as internal plate control in four
wells; (b) one plate for the positive control with 3,4-DCA (4 mg/L)
in 20 wells and dilution water as internal plate control in four
wells; (c) one plate for the negative control with dilution water
in 24 wells; and (d) if appropriate, one plate for the solvent control
with the solvent in the dilution water in 20 wells and dilution
water as internal plate control in four wells.
2.3.5. Incubation
The 24-well plates were covered with self-adhesive plate sealer
tape (e.g. Nunc, Denmark) or lids provided with the plates and
incubated at 26.0 ± 1.0 C for 96 h and a light phase of 12–16 h.
2.3.6. Renewal of the test solutions/controls
The test solutions/controls were renewed on a daily basis after
recording any lethal effects on the embryos; at least 90% of the
volume of each well was removed without touching the embryo
and immediately replaced with freshly prepared test solutions.
2.3.7. Recording of lethal effects and hatching rate
At 24, 48, 72 and 96 h, the following endpoints were recorded:
coagulation of the embryo, non-detachment of the tail, non-
formation of somites, non-detection of the heartbeat (only visible
from 48 h onwards) and the number of hatched embryos.
Photographs illustrating lethal effects are given in OECD TG 236
(OECD, 2013).
2.3.8. Acceptance criteria for a qualified run
A qualified run had to meet the following criteria: (a) fertility
rate of the parent generation P70%; (b) dissolved oxygen
concentration P80% of the air saturation value at the beginning
of the test; (c) the water temperature had been maintained at
26.0 ± 1.0 C in 24-well plates at all times during the test; (d) over-
all survival of embryos in the negative control and, if relevant, in
the solvent control was P90% until the end of exposure; and (e)
Table 3
List of chemicals tested.
Chemical CAS no MW (g/mol) Log Kow HLC (Pas-m3/mole) Concentrations tested Use
Triclosan1 3380-34-5 289.55 4.76 0.00051 0.075, 0.15, 0.3, 0.6, 1.2 mg/L PPP/B
Dibutyl maleate1 105-76-0 228.29 4.16 0.0768 0.25, 0.5, 1, 2, 4 mg/L C
3,4-Dichloroaniline1 95-76-1 162.02 2.69 0.19 0.5, 1, 2, 3.7, 4, 8 mg/L C
2,3,6-Trimethylphenol1 2416-94-6 136.2 3.15 0.399 8, 12, 18, 27, 40.5 mg/L FF
6-Methyl-5-heptene-2-one1 110-93-0 126.2 2.06 21.5 25, 42.5, 72.25, 122.825, 208.03 mg/L FF
Sodium chloride1 7647-14-5 58.44 0.46 3.580E025 1, 2, 4, 8, 16 g/L C
Ethanol1 64-17-5 46.07 0.31 0.574 5.3, 8, 12, 18, 27 g/L C
Methylmercury (II) chloride2 115-09-3 251.08 0.41db NA 0.00625, 0.0125, 0.025, 0.05, 0.1 mg/L C
Copper (II) sulphate pentahydrate2 7758-99-8 249.68 NA NA 0.15, 0.3, 0.6, 1.2, 2.4 mg/L PPP/B
4,6-Dinitro-o-cresol2 534-52-1 198.14 2.13db 1.4E06db 0.18, 0.32, 0.58, 1.05, 1.89 mg/L PPP/B
2,4-Dinitrophenol2 51-28-5 184.11 1.67db 8.06E08db 0.625, 1.25, 2.5, 5, 10 mg/L C
Merquat 1002 26062-79-3 200,000–350,000 2.49est 7.2E12est 0.1. 0.2, 0.4, 0.8, 1.6 mg/L C
Luviquat HM 5522 95144-24-4 400,000 1.38est 1.87E14est 0.125, 0.25, 0.5, 1, 2 mg/L C
Tetradecyl sulfate sodium salt2 1191-50-0 316.43 2.67est 3.25E07est 0.156, 0.3125, 0.625, 1.25, 2.5 mg/L C
Malathion2 121-75-5 330.4 2.36db 8.39E10est 0.5, 1, 2, 4, 8 mg/L PPP/B
Prochloraz2 67747-09-5 376.67 4.1db 7.58E12est 0.5, 1, 2, 4, 8 mg/L PPP/B
1-Octanol2 111-87-5 130.23 3.00db 2.45E05db 2.5, 5, 10, 20, 40 mg/L C
Carbamazepine 298-46-4 236.28 2.45db 1.08E10est 54.7, 76.5, 107.1, 150, 210 mg/L P
Dimethyl sulfoxide2 67-68-5 78.13 1.35db 4.96 E08est 10, 17, 28.9, 49.13, 83.521 mg/L C
Triethylene glycol2 112-27-6 150.17 1.75est 3.16E011est 20, 30, 45, 67.5, 101.25 mg/L C
1 = tested in Phase 1; 2 = tested in Phase 2; NA = not available; MW =molecular weight; HLC = Henry’s law constant; db = experimental database match; est = estimated;
Note: log Kow and HLC were estimated using EPISUITE 4.0 (2008) except when measured values were available (cited within EPISUITE); C = industrial chemicals; PPP/
B = plant protection products/biocides; P = pharmaceuticals; FF = flavours/fragrances; All chemicals (at the highest purity available) were purchased from Sigma–Aldrich
(same lot number) except dimethyl sulfoxide (Gruessing GmbH).
1-5 = five test concentrations; nC = negative control (dilution water); iC = internal plate control (dilution water); 
pC = positive control (3,4-dichloroaniline 4mg/L); sC = solvent control 
Fig. 1. Zebrafish embryo acute toxicity test – 24-well plate layout (as given in OECD TG 236).
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In addition, there was the option of excluding individual plates (i.e.
test concentrations) from the LC50 calculation if there were more
than one dead embryo in the internal plate control.
2.3.9. Test condition parameters
For each run, the following parameters were measured by using
microprobes, carefully pooling the solutions or by the use ofsurrogate beakers: dissolved oxygen concentration, pH value, total
hardness, temperature and conductivity. Measurements were
performed at least at the following time points: 0 h, 24 h (old
solution), 72 h (fresh renewal solution), and 96 h.
2.3.10. Confirmation of nominal concentrations
Two laboratories conducted analytical measurements of stock
solutions and test solutions of a selection of chemicals (cf. Table 4).
Table 4
Results of analytical measurements (stock solutions, selected runs) performed by two laboratories.
Chemical Laboratory Study phase Sample type Analytical method Overall % of nominal
Mean (SD)
3,4-DCA P&G Qualification Stocks (4 labs) HPLC-UV 101.1 (3.7)
Exposure static HPLC–MS/MS 80.6 (3.7)
Exposure (static renewal) HPLC–MS/MS 78.9 (8.0)
Ethanol P&G Phase 1 Exposure TOC 92.1 (1.3)
Sodium chloride P&G Phase 1 Stock Specific conductance 104.8 (2.0)
Exposure Specific conductance 100.1 (3.8)
Trimethyl phenola P&G Phase 1 Stock HPLC-UV 103.1 (5.0)
Exposure HPLC-UV 104.8 (1.3)
6-Methyl-5-hepten-2-onea P&G Phase 1 Stock HPLC-UV 100.2 (0.2)
Exposure HPLC–MS/MS 80.9 (8.1)
Dibutyl maleatea P&G Phase 1 Stock HPLC-UV 103.9 (4.3)
Exposure HPLC–MS/MS 62.2 (4.2)
Triclosana P&G Phase 1 Stock HPLC-UV 100.2 (0.2)
Exposure HPLC–MS/MS 96.6 (3.6)
Tetradecyl sulphatea P&G Phase 2 Stock HPLC–MS/MS 112.5 (4.6)
Exposure HPLC–MS/MS 71.9 (24.4)
1-Octanola P&G Phase 2 Stock HPLC–MS/MS 90.0 (7.2)
Exposure HPLC–MS/MS 77.5 (10.4)
Copper sulphatea P&G Phase 2 Stock ICP-MS 72.9 (9.9)
Exposure ICP-MS 63.2 (2.2)
Carbemazepineb IPO-Pszczyna Phase 2 Exposure HPLC-UV 94.8 (2.6)
Prochlorazc IPO-Pszczyna Phase 2 Stock HPLC-DAD 81.5 (12.8)
Exposure HPLC-DAD 84.5 (8.8)
a Data from one run.
b Data from four runs.
c Data from three runs.
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range used were selected and detailed summaries of each
procedure, method performance and instrument conditions are
given in OECD (2011, 2012). Of the 20 chemicals evaluated in the
ring trial, 12 were subjected to analytical confirmation as a means
to determine the likelihood that a wide array of chemicals could
ultimately be assayed if desired (in other words, proof of principle
that high quality analytical confirmation of exposure could be
achieved when conducting this assay).2.3.11. Data collection
Laboratories submitted their raw data (lethal effects, hatching,
test condition parameters, deviation from the SOP and/or trial plan,
etc.) using defined reporting templates to the study coordinator.
Data were subjected to a careful check for completeness and
consistency. Laboratories were asked to also provide the data of
non-qualified runs. The raw data of qualified runs were transferred
to Excel sheets for LC50 calculation and further statistical analysis.2.3.12. Data analysis, experimental design assessment and statistics
Following compilation of survival and mortality observations
the data were subjected to LC50 determinations at each time point
(24, 48, 72 and 96 h). The primary model fit to the experimental
results was the two-parameter logistic function. This model has
two parameters, LC50 and b, where
PrðLethalityÞ ¼ 1
1þ expðbðx LC50ÞÞ
Both x and LC50 are on the log-scale of concentration. This
logistic regression model is one of the models broadly recom-
mended in OECD guidance document 54 (OECD, 2006b). This
model implies that there is no background mortality (i.e. lethality
in negative control is close to 0), and, in fact, observed background
mortality does not contribute to model parameter estimation.
Using this model, the control data role is solely to assess
experimental quality. Models are fit using iterative numerical cal-
culations and convergence of the numerical model fitting processwas confirmed prior to any other evaluation. Upon confirmation,
the fit of the primary model was checked using graphical summa-
ries. Only in rare cases, it was necessary to use other models such
as Probit, binomial, or Trimmed Spearman–Karber. Confidence
intervals (95%) for the LC50s were determined by the profile like-
lihood method (Meeker and Escobar, 1995). Detailed descriptions
of the statistical analyses are provided in the OECD validation
study reports (OECD, 2011, 2012). In some cases, the results of
experiments were ill-suited to the estimation of an LC50 and the
confidence interval; these data sets were excluded from the sum-
maries related to LC50 estimation (for example, the chemical did
not elicit substantial mortality at the time interval investigated).
A simple criterion was used to determine inclusion in further anal-
ysis: the prediction model had to achieve a response rate of at least
50% at the maximum dose tested. All calculations were performed
using the statistical package R (R Development Core Team, 2011).
In order to facilitate intra- and inter-laboratory comparisons,
coefficients of variation (CVs) were computed from data produced
by each individual laboratory and each chemical tested as a mea-
sure of intra-laboratory reproducibility at 48 and 96 h of exposure.
Mean LC50 values for each chemical per laboratory were then used
to also develop CVs as a measure of inter-laboratory reproducibil-
ity for that chemical. In general, the VMG considered CVs less than
30% to be of ‘‘high quality’’ in that these would be judged to have a
small or reasonable level of intra- or inter-laboratory variability.
Graphical displays of all tests were inspected for general confor-
mance to the LC50 model predictions as were summaries of LC50s
and their 95% confidence intervals compiled by each laboratory
and for each chemical.
The validation study encompassed 20 chemicals and employed
an experimental design characterised, in general terms, as a semi-
static exposure to five equally spaced concentrations plus controls
using 20 embryos per exposure concentration as discussed in Sec-
tion 2.3.4 and depicted in Fig. 1. Clearly it is desirable to identify
the smallest acceptable group size because they will save time,
expense and organisms exposed to chemicals. In order to evaluate
this benchmark 20 per group design versus others with a lower
level of replication, an extensive set of statistical simulations
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given above were implemented, and the relative performance of
the different study sizes were compared. As the true LC50 is known
in these simulation exercises, the performance of the model esti-
mation relative to the truth can be quantified under the assumed
conditions (for example, that the model used really is the true
underlying model for the responses, etc.).
Numerous combinations of group sizes, dose–response slopes,
and the placement of the doses relative to the true LC50, were
evaluated. Four group sizes were evaluated: 7, 10, 15, and 20
embryos per treatment group. Historically, 20 organisms per group
is a standard recommendation (Jensen, 1972; US EPA, 2002),
although others have suggested that group sizes can be as small
as seven (Douglas et al., 1986; OECD, 1992).
Various summaries of the simulations were performed, such as
the probability that an LC50 could be estimated, the bias and dis-
tribution of LC50 estimates, the average width of confidence inter-
vals, the coverage probabilities of the intervals, and whether the
intervals are enclosed within the range of concentrations tested.
3. Results
3.1. Training of the laboratories – testing of 3,4-DCA
The feedback from the laboratories during the training and the
in-life evaluation of the toxicity of 3,4-DCA to fish embryos
improved the comprehensiveness of the SOP. For example,
standardisation of the description of heartbeat observations was
refined, and the time andminimum levels ofmagnification required
to make observations were increased. The 3,4-DCA LC50 values
generated in eleven laboratories as well as the CVs as a measure
for intra- and inter-laboratory reproducibility are given in Tables
6–8. The 3,4-DCA data set was the single most-studied chemical in
the entire validation as a consequence of its use as a demonstration
of laboratory competence and as a subsequent permanent positive
control during all other tests at a set concentration of 4 mg/L.
3.2. Analytical measurements
An initial set of studies conducted with 3,4-DCA in which expo-
sures were static for 96 h indicated substantive losses (on average
about 20% with some exposures being less than 20%). Daily renew-
als for exposures were therefore employed in all subsequent
chemical investigations. Test vessels and 24 well plates were also
pre-saturated with test solutions and this requirement was
included into the SOP. Initial investigations of 3,4-DCA stock
solutions of four laboratories indicated they were well prepared
(mean of 101.1% of nominal was derived) (Table 4). A similar mean
percentage of nominal from static renewal tests was found (78.9%)
indicating that losses were occurring early in the tests (within the
first 24 h). However, as noted above, these observations resulted in
an overall conservative approach to perform all exposures with
daily renewals. Analytical verification of exposure was conducted
for 13 of the 20 chemicals and involved daily analysis of initial
and pooled 24 h old test solutions.
Results of the analytical measurements are given in Table 4. It
should be noted that the LC50 values throughout have not been
adjusted for measured exposure concentrations as not all laborato-
ries performed analytical determinations. However, for compara-
tive purposes, this was deemed reasonable by the VMG as a
consistent basis for the assessments.
3.3. Phase 1 – testing of six chemicals
For the six chemicals tested in Phase 1, the laboratories pro-
vided 81 runs to the coordinator, out of which four runs did notmeet the acceptance criteria (three due to increased lethality in
the negative control and one due to a mistake in preparation of
the stock solution) and had to be repeated. Table 5 lists the CVs
for each chemical (n = 3) and laboratory (LC50 values for each
run are available in OECD, 2011). The 27 CVs calculated ranged
from 0% to 46.64% at 48 h and from 2.6% to 37.99% at 96 h. In gen-
eral, intra-laboratory reproducibility was good with the vast
majority of CVs below 20%; i.e. at 48 h 22 CVs were <20%, three
CVs ranged from 20% to 30% and two CVs from 40% to 50% and
at 96 h 22 CVs were <20%, three CVs ranged from 20% to 30% and
two CVs from 30% to 40%).
As shown in Table 7, for inter-laboratory reproducibility, the
CVs ranged from 7.09% to 22.1% at 48 h and from 1.8% to 23.6%
at 96 h for four of the six chemicals. A higher variability was evi-
dent for the highly volatile 6-methyl-5-hepten-2-one with CVs of
65.85% at 48 h and 56.32% at 96 h. For 2,3,6-trimethylphenol,
LC50 values of four laboratories only slightly deviated as demon-
strated by a CV of around 16% which increased to 41%, when
including the results of laboratory G. The results of Phase 1 for
48 h and 96 h are illustrated in Figs. 2 and 3, respectively.
Based on the Phase 1 results, the VMG concluded that the ZFET
was successfully transferred from the lead laboratory to the
participating laboratories and that promising results had been
obtained regarding its reproducibility. As a consequence the VMG
– supported by AHEG FET – decided to progress to Phase 2.
3.4. Phase 2 – testing of 13 chemicals
For the 13 chemicals tested in Phase 2, the laboratories pro-
vided 153 runs to the coordinator. Ten runs did not meet the
acceptance criteria for the following reasons: five runs due to
increased lethality in the negative control (>10%), three runs due
to increased lethality in the internal plate control (>1 dead embryo
per plate), one run due to reduced lethality in the positive control
(<30%) and one run due to the low fertility rate of the parent gen-
eration (<70%). These runs were repeated and subsequently met
the acceptance criteria.
Table 6 summarises the CV values (n = 3) obtained at 48 and
96 h and the intra-laboratory reproducibility of the ZFET in the
nine laboratories of Phase 2 (LC50 values for each run are available
in OECD, 2012). For five chemicals (Merquat 100, Luviquat HM 552,
malathion, prochloraz and carbamazepine), it was not possible to
estimate the LC50 value for each run at 48 h, and, consequently,
CVs could not be calculated. The 38 CVs calculated ranged from
0% to 35.7% with only three CVs above 30%. At 96 h, CVs could
not be calculated for prochloraz in two laboratories, since LC50
values could only be derived in one run per chemical. The 49 CVs
calculated ranged from 1.3% to 37.2% with only four CVs above 30%.
In general, inter-laboratory reproducibility was good (see
Table 7) with CVs below 26% at 48 and 96 h for nine chemicals,
whereas variability was higher for four chemicals (prochloraz, cop-
per (II) sulphate pentahydrate, Merquat 100, methylmercury (II)
chloride) with CVs ranging from 30.6% to 50.2%. The results of
Phase 2 are presented graphically in Figs. 4 and 5, for the 48 h
and 96 h results, respectively.
3.5. Time-dependent changes in toxicity for Phase 2 chemicals
In order to assess time-dependence of changes in toxicity, LC50
values were also calculated for 24 h and 72 h for the 13 Phase 2
chemicals. Based on these determinations, it was expected to be
possible to develop recommendations to perform the ZFET at dura-
tions shorter than 96 h for certain groups of chemicals. Distinct
temporal patterns of toxicity were evident; for example, groups
of chemicals could be identified where toxicity (a) was observed
primarily early during the in exposure period (e.g. copper (II)
Table 5
Intra-laboratory reproducibility of the zebrafish embryo acute toxicity test as indicated by the coefficient of variation. Results are for the six Phase 1 chemicals tested in three runs
and 3,4-dichloroaniline used for the training of the laboratories.
Chemicals Laboratories – CV (%) of LC50 at 48 h (n = 3) Laboratories – CV (%) of LC50 at 96 h (n = 3)
A B C D F G A B C D F G
Triclosan – 2.14 14.15 – 8.68 17.73 – 16.79 37.99 – 5.86 2.6
Dibutyl maleate 10.27 – 23.92 0 13.23 4.73 19.16 – 10.49 10.92 25.43 14.12
2,3,6-Trimethylphenol 14.94 – 13.97 21.22 15.01 20.44 14.94 – 13.7 22.43 13.99 18.83
6-Methyl-5-hepten-2-one – 41.04 46.64 – 1.25 5.68 – 21.68 34.63 – 2.28 3.61
Sodium chloride – 12.09 10.18 – 6.25 19.48 – 7.73 6.36 – 8.96 19.48
Ethanol 15.13 – 14.16 7.1 7.1 0.02 15.71 – 14.14 3.08 5.5 5.1
3,4-Dichloroaniline 58.8a 27.2a 7.3 10.00 24.6 14.9 58.5a 17.1a 16.6 4.40 17.9 17.2
CV = coefficient of variation; – = not tested in the respective laboratory.
a Based on 2 runs; individual LC50 values are available in OECD (2011).
Fig. 2. Estimates of LC50 for each experimental run in Phase 1 at 48 h. The laboratory codes are given on the vertical edges. Estimated LC50 is shown as an open circle, and the
95% confidence interval is the horizontal line. The LC50 is shown in red, without a confidence interval, when the LC50 takes a value outside of the range of concentrations
tested. The dark grey boxes delimit the range of concentrations tested, and the light vertical lines within are the concentrations tested. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
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prochloraz, 1-octanol, ethanol, 2,3,6-trimethylphenol, and sodium
chloride), (b) continued to steadily increase throughout the expo-sure (e.g. carbamazepine, malathion, dimethyl sulfoxide, 3,4-DCA,
6-methyl-5-hepten-2-one), (c) rapidly changed after 24 h (e.g.
methylmercury (II) chloride, 2,4-dinitrophenol, 4,6-dinitro-o-
Fig. 3. Estimates of LC50 for each experimental run in Phase 1 at 96 h. The laboratory codes are given on the vertical edges. Estimated LC50 is shown as an open circle, and the
95% confidence interval is the horizontal line. The LC50 is shown in red, without a confidence interval, when the LC50 takes a value outside of the range of concentrations
tested. The dark grey boxes delimit the range of concentrations tested, and the light vertical lines within are the concentrations tested. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
504 F. Busquet et al. / Regulatory Toxicology and Pharmacology 69 (2014) 496–511cresol, dibutyl maleate, and triclosan), and (d) was mostly
expressed following hatch at 72 h (Merquat 100, Luviquat HM
552). Out of these, only the last grouping comprised a single
category of chemicals: Merquat 100 and Luviquat HM552 are
medium-sized, cationic polymers. All other groupings based on
time-dependent toxicity were mixtures of various chemical classes
or modes of action. Examples of time patterns for toxicity by rep-
resentative chemicals are given in Fig. 6.
3.6. Evaluation of the hatching rate
In addition to the four apical lethal endpoints, the laboratories
also recorded numbers of hatched embryos at each time point. This
information was used to calculate the overall hatching rate in the
negative control and to compare whether inter-laboratory differ-
ences for hatching may have affected LC50 determinations. The
evaluation revealed that negative control hatching rates were high
and relatively consistent (Fig. 7). Over 80% of the negative controlzebrafish embryos hatched by 72 h and the 90th percentile
exceeded 90% hatch by 96 h. 80% hatch at 96 h was not achieved
in three out of 153 runs (each in different laboratories). The 96 h
LC50 appears to be unrelated to the percentage of embryos
hatched at 72 h.
3.7. Performance of the positive control during LC50 tests in the ZFET
Based on the early findings from qualification runs employing
3,4-DCA as the toxicant of interest, a set concentration of 3,4-
DCA was chosen to be used as a permanent positive control in all
subsequent studies of the 19 test chemicals. The six laboratories
during Phase 1 had mean 96 h LC50s that ranged from 1.2–
3.54 mg/L 3,4-DCA. To ensure the 3,4-DCA would elicit a strong
response (>30%) at all times, a concentration of 4 mg/L was
selected as a means to ensure the ability to assess the relative sen-
sitivity of the lot of zebrafish embryos used for testing. At 24, 48,
72, and 96 h, embryos exposed to 4 mg/L 3,4-DCA resulted in
Table 6
Intra-laboratory reproducibility of the zebrafish embryo acute toxicity test as indicated by the coefficient of variation. Results are for the thirteen Phase 2 chemicals tested in three
runs and 3,4-dichloroaniline used for the training of the laboratories.
Chemicals Laboratories – CV (%) of LC50 at 48 h (n = 3) Laboratories – CV (%) of LC50 at 96 h (n = 3)
B D E F G H I J K B D E F G H I J K
Methylmercury (II) chloride – 5.1 – 0 – – – 3.7 – – 11.2 – 3.5 – – – 2.1 –
Copper (II) sulphate
pentahydrate
– – – 14.9 12.9 9.9 16.5 – – – – – 14.9 12.9 9.2 7.2 – –
Tetradecyl sulphate sodium
salt
35.7 – – 4.5 32.8 15.9 – – – 34 – – 4.5 28.2 15.9 – – –
4,6-Dinitro-o-cresol – – 30.9 27.8 – 9.7 – – 26.5 – – 1.7 14.3 – 12.4 – – 18.5
Merquat 100 – – – NC – NC – NC NC – – – 17.1 – 26.7 – 37.2 1.9
Luviquat HM 552 – – – NC – NC NC – NC – – – 7.8 – 11.6 13.5 – 9.1
2,4-Dinitrophenol – 20.6 – 1.2 – – 23.6 – 8.4 – 32.7 – 16.8 – – 1.6 – 5.3
Prochloraz – – NC 11.8 – 8.9 NC – – – – NC 11.3 – 8.7 NC – –
Malathion NC – – 14.4 – – – NC 18.7 19 – – 8.8 – – – 10.3 33.2
1-Octanol 24.1 – – 4.9 27.9 11.8 – – – 24.1 – – 4.9 28 13.3 – – –
Carbamazepine – 5.3 NC 1.5 – – – – 15.9 – 1.3 6.1 6.5 – – – – 3.4
Dimethyl sulfoxide – – – 1.9 – 12.1 – 10.6 7.8 – – – 1.9 – 9.7 – 8.5 7.8
Triethylene glycol 15.4 – 6.5 2.6 – – 7.9 – – 2.7 – 9.7 8.9 – – 1.6 – –
3,4-Dichloroaniline – – 20.4 – – 5.47 12.28 34.09 10.08 – – 18.9 – – 5.5 17.72 19.03 22.42
NC = not calculated due to insufficient number of values; CV = coefficient of variation; – = not tested in the respective laboratory; individual LC50 values are available in OECD
(2012).
Table 7
Inter-laboratory reproducibility of the zebrafish embryo acute toxicity test as indicated by the coefficient of variation. Results are for 20 chemicals tested in at least three
laboratories.
Chemicals Tested in
n labs
48 h CV
(%)
Number of labs
contributing to CV
calculation
Number of runs
contributing to CV
calculation
96 h CV (%) Number of labs
contributing to CV
calculation
Number of runs
contributing to CV
calculation
Phase 1
3,4-Dichloroaniline 7a 22.1 (33.7)b 5 (7) 15 (19) 23.6 (33.4)b 5 (7) 15 (19)
Triclosan 4 9.24 4 12 1.8 4 12
Dibutyl maleate 5 17.64 5 15 13.26 5 15
2,3,6-Trimethylphenol 5 16.37 (40.9)c 5 15 15.77 (40.88)c 5 15
6-Methyl-5-hepten-2-one 4 65.85 4 12 56.32 4 12
Sodium chloride 4 16.93 4 12 18.85 4 12
Ethanol 5 7.09 5 15 4.78 5 15
Phase 2
3,4-Dichloroaniline 4 27.4 4 12 26.4 4 12
Methylmercury (II) chloride 3 46.9 3 9 50.2 3 9
Copper (II) sulphate pentahydrate 4 41.7 4 12 33.6 4 12
Tetradecyl sulphate sodium salt 4 25 4 12 25.8 4 12
4,6-Dinitro-o-cresol 4 2.8 4 12 7.5 4 12
Merquat 100 4 NC 1 1 40.8 4 12
Luviquat HM 552 4 NC 1 1 24.8 4 12
2,4-Dinitrophenol 4 23.5 4 12 22.7 4 12
Prochloraz 4 5.8 2 6 30.4 4 8
Malathion 4 25.8 3 6 13 4 12
1-Octanol 4 5.9 4 12 5.9 4 12
Carbamazepine 4 6.4 4 9 3.8 4 12
Dimethyl sulfoxide 4 14.9 4 12 6.6 4 12
Triethylene glycol 4 8.4 4 12 6.3 4 12
NC = not calculable, since LC50 could not be determined.
a Laboratory (E) was trained in Phase 1 but participated in Phase 2.
b Values in brackets include LC50 of two laboratories providing only 2 qualified runs.
c Values in brackets include LC50 of laboratory G.
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respectively (n = 246 for the first three time periods and n = 234
for 96 h).
3.8. Impact of the group size on the estimation of LC50 in the ZFET
While a full description of results of this simulation study is
beyond the scope of this paper (more details are given in Annex
X of OECD, 2012), it was found that the statistical quality of LC50
estimation is sensitive to the sample size when related to the slope
of the concentration–response curve, and the position of the true
LC50 relative to the concentrations tested. Specifically, the more
shallow the concentration–response curve, and the closer the trueLC50 is to the edges of the concentrations tested, the greater the
benefit of 20 embryos per group versus the smaller sizes evaluated.
Because of these observations, using 20 embryos per group is well
justified, especially in the context of a validation study meant to
demonstrate the feasibility of the method. For example, using 7
or 10 embryos per group, there is a 2–5% chance that even if the
concentrations selected are perfectly centred on the LC50, the
model will not work if the slope of the response is shallow, because
there is insufficient evidence of a concentration–response trend.
However, that same problem disappears for the 15 or 20 embryos
per group designs, where under otherwise identical conditions the
trend is statistically significant in 100% of cases, and allows for full
model estimation. Note as well that there is always a decline in the
Fig. 4. Estimates of LC50 for each experimental run in Phase 2 at 48 h. The laboratory codes are given on the vertical edges. Estimated LC50 is shown as an open circle, and the
95% confidence interval is the horizontal line. The LC50 is shown in red, without a confidence interval, when the LC50 takes a value outside of the range of concentrations
tested. The dark grey boxes delimit the range of concentrations tested, and the light vertical lines within are the concentrations tested. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
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of the concentrations tested, and this is always a measurably larger
problem as the group size decreases. We clearly observed this
problem for several chemicals, such as those presented in Figs. 2–
5 where the LC50 is clearly not centred in the dose range that was
employed. This will always be an issue to consider because the
LC50 itself is a function of the duration of exposure. Therefore,
for the purpose of the validation study, this simulation study
confirmed that use of 20 zebrafish embryos per concentration in
a series of five concentrations was highly recommended.4. Discussion and conclusions
Demonstration of the validity of a test method (its reliability
and relevance for a given purpose) is an asset for its progression
to regulatory acceptance, for example, development of an OECD
test guideline, and its subsequent use in the regulatory framework
(OECD, 2005).This is the first time that the reliability (intra- and inter-labora-
tory reproducibility) of the ZFET has been evaluated with an agreed
standardised protocol in an international multi-laboratory study
testing 20 chemicals, each in three independent runs in at least
three laboratories.
The results obtained in the 11 participating laboratories indi-
cate a good intra- and inter-laboratory reproducibility with
CVs < 30% regardless of the chemical or the laboratory and the var-
ious zebrafish strains used. The high inter-laboratory variability in
the results of 6-methyl-5-hepten-2-one might be explained by its
high volatility (50 times more volatile than ethanol) and possible
differences in the handling of the chemical during the preparation
of the stock solutions and test concentrations. In addition, none of
the laboratories achieved 100% lethality with this chemical (three
achieved at least 50% and one 30% in the highest concentration),
indicating that the test concentrations chosen were probably not
adequate. For three chemicals (Merquat 100, methylmercury (II)
chloride, copper (II) sulphate pentahydrate), the higher inter-
laboratory variability (CVs > 30%) might be linked to their high
Fig. 5. Estimates of LC50 for each experimental run in Phase 2 at 96 h. The laboratory codes are given on the vertical edges. Estimated LC50 is shown as an open circle, and the
95% confidence interval is the horizontal line. The LC50 is shown in red, without a confidence interval, when the LC50 takes a value outside of the range of concentrations
tested. The dark grey boxes delimit the range of concentrations tested, and the light vertical lines within are the concentrations tested. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
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close to 0 were magnified and resulted in a larger CV. With pro-
chloraz, tested close to its limit of solubility, two laboratories
had problems in dissolving the chemical, and LC50 values could
only be calculated for one run per laboratory. Belanger et al.
(2013) briefly reviewed other aquatic toxicity tests and their
respective laboratory variabilities. The intra- and inter-laboratory
CVs for the ZFET ring trial compare favourably or better than exist-
ing accepted methods. For example, the US EPA (2001) provided an
inter-laboratory assessment of the fathead minnow acute toxicity
test with KCl involving 13 laboratories. In these assessments, the
inter-laboratory CV for KCl was 19.7% and intra-laboratory CV
was 7.6%, which were similar to the ZFET NaCl toxicity results cited
in Table 5. Grothe and Kimerle (1985) showed slightly greater var-
iability in effluent toxicity tests with Daphnia magna compared to
US EPA (2001) or the present ZFET validation results. Ashley and
Mallett (1990) reported even larger levels of variability (CVs of
30% and greater) for the juvenile rainbow trout chronic growth test
(OECD TG 215; OECD, 2000). TNO (Hanstveit, 1991) conducted alarge international ring test for the marine diatom inhibition test
with Skeletonema costatum. The primary conclusions drawn from
these investigations were that intra-laboratory variability is
always less than inter-laboratory variability, acute test variability
is less than chronic test variability, and under ideal conditions,
intra-laboratory variability is approximately 20% and inter-
laboratory variability is approximately 30%.
With regards to the two high molecular weight chemicals
(Merquat 100 and Luviquat HM 552) for which hardly any lethality
was observed within the 48 h exposure period and LC50s were
mostly confined to 96 h exposures (roughly 24 h post-hatch), it
was assumed that the chorion had acted as a barrier. This is sup-
ported by previous work of Henn and Braunbeck (2011) where
Luviquat HM 552 (Molecular weight 400,000 Dalton) was already
highly toxic at 48 hpf to zebrafish embryos dechorionated at
24 h hpf. In fact, it was only possible to find this significant time-
dependent pattern of toxicity for these two cationic polymers,
but not for any of the other chemical categories. Nevertheless,
other chemicals might possess properties that would result in
Fig. 6. Time patterns of toxicity observed in ZFET validation studies. (A) Tetradeyl sulphate as an example of a chemical whose toxicity is expressed primarily early in
exposure resulting in LC50s that do not change through time, (B) DMSO as an example of a chemical whose LC50 steadily declines during exposure; (C) Dintro-o-cresol as an
example for a chemical whose LC50 changes rapidly after 24 h; and (D) Merquat as an example of a chemical where most toxicity is observed following hatch. (For the colour
version of this figure, the reader is referred to the web version of this article.)
Fig. 7. Percent hatch at each time point in controls during Phase 2. The light solid blue, medium dashed blue, and short dashed blue lines are the median, 75th percentile and
90th percentile (n = 153 tests). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
508 F. Busquet et al. / Regulatory Toxicology and Pharmacology 69 (2014) 496–511erroneous assessments of overall potential toxicity to fish, at least
if the ZFET was terminated before hatch and this may also repre-
sent stage-specific differences in sensitivity. Several chemicalswhere toxicity is somewhat time-dependent, resulted in LC50s that
continue to slowly decrease through time (Fig. 6), as observed in
other test systems. Other chemicals, whose toxicity is more closely
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Fig. 8. Distribution of mortality by 4 mg/L 3,4-DCA for 48 h and 96 h (used as positive control in the zebrafish embryo acute toxicity tests). (For the colour version of this
figure, the reader is referred to the web version of this article.)
Table 8
Comparison of ZFET LC50 values and the 96 h acute fish LC50 values.
Chemicals ZFET mean LC50 (mg/L) Fish acutea LC50 (mg/L)
min–mean–max
48 h 96 h 96 h
Methylmercury (II) chloride 0.042 0.028 0.031–0.036–0.42 (2)b
Copper (II) sulphate pentahydrate 0.308 0.291 0.008–0.224–0.749 (11)
Triclosan 0.42 0.3 0.250–0.283–0.360 (5)
4,6-Dinitro-o-cresol 0.723 0.567 0.066–0.682–2.2 (7)
Dibutyl maleate 1.38 0.7 0.6 (1)
3,4-Dichloroaniline 3.2 2.7 (5) 1.94–6.947–9.8 (10)
2,4-Dinitrophenol 4.123 3 0.39–6.843–27.1 (19)
Merquat 100 NC 0.496 0.3–4.4–6.52 (2)c
Luviquat HM 552 NC 0.876 0.748 (1)
Tetradecyl sulphate sodium salt 0.337 0.339 3.14–3.33–3.55 (2)
Malathion 6.123 4.56 0.0028–0.266–25 (44)
Prochloraz 4.461 5.6 0.53–0.583–0.68 (3)
2,3,6-Trimethylphenol 10.9d 10.8d 8.2 (1)
1-Octanol 20.7 20.675 13–14.03–17.68 (7)
Carbamazepine 177 153 43 (1)
6-Methyl-5-hepten-2-one 279 243 85.7 (1)
Sodium chloride 5340 5140 1295–7244–12946 (23)
Ethanol 13200 12000 42–1828–14200 (3)
Dimethyl sulfoxide 40200 34100 34000–35782–38500 (3)
Triethylene glycol 71300 54800 59900–71251–92500 (5)
The bold values are the geometric mean.
a Retrieved from Belanger et al. (2013).
b Numbers in brackets represent the number of studies. NC = LC50 could not be calculated.
c Source: Material Safety Data Sheet (Sigma Aldrich Version 1.4; 2006).
d Without laboratory G.
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Kow), or whose potency is very close to the limits of solubility
would also derive more reliable LC50s by extending exposure
beyond hatch.
Evaluation of the effect of the group size confirmed that the use
of 20 embryos per concentration was preferable. It is therefore
recommended that the group size of 20 embryos should be main-
tained for the ZFET to ensure the accuracy of the test. In practical
terms, this also has the benefit of reducing the likelihood that, if
fewer embryos per concentration are used, multiple (non-random)exposure concentrations would be employed on the same expo-
sure plate (assuming a 24-well plate is used).
Many aquatic toxicity test guidelines such as the OECD TG 203
fish acute toxicity test (OECD, 1992) provide less acceptance crite-
ria than the now available fish embryo acute toxicity test (OECD TG
236). More rigorous validation and carefully constructed trial plans
have derived additional test acceptance criteria to be applied in
OECD TG 236, and hopefully other guidelines in the future. For
example, the hatching rate in the negative control was consistent
and it is a useful endpoint included in the OECD TG 236 acceptance
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(Fig. 7). In addition, no other environmental test guideline has a
mandatory positive control conducted in parallel to the main test.
Typically, test performance criteria are loosely stated in test guide-
lines to provide flexibility by the test laboratory. Studies with ref-
erence chemicals are recommended to be performed on a routine
basis (usually every six months or so) and reported alongside the
test chemical of interest. In the OECD TG 236, a positive control
of 4 mg/L 3,4-DCA is required and is used to judge acceptability
of the assay. The concentration has been selected to ensure a
response (Fig. 8) and routinely this concentration would result in
approximately 80% mortality by 96 h. Test acceptance criteria ulti-
mately stated that exposure to 4 mg/L 3,4-DCA must exceed 30%
mortality to be considered valid.
Although assessment of the predictive capacity of the ZFET for
acute fish toxicity had not been an objective of the study, the
results gained with the ZFET were compared to acute fish toxicity
data (Table 8). For this comparison, 96 h acute fish toxicity data
were retrieved from Belanger et al. (2013). The comparison reveals
that most of the ZFET LC50s are in the same range as the juvenile/
adult fish data. Data from our study indicated that chemicals with
specific modes of action (malathion, prochloraz and carbamaze-
pine) proved less toxic to zebrafish embryos than to adult fish.
However, it should be noted that prochloraz and carbamazepine
have very limited fish data. Others have noted that comparisons
of FET and acute fish toxicity tests have severe limitations. Often
this is a result of poor, but accepted acute fish toxicity data
(Lammer et al., 2009; Raimondo et al., 2010; Scholz et al., 2013).
Testing of compounds that require metabolic activation before elu-
cidating toxic effects is an important topic. On the one hand, Weigt
et al. (2011, 2012) successfully tested a wide range of compounds
that require metabolic activation by cytochrome P450 enzymes
with zebrafish embryos at physiological concentrations. On the
other hand, there are single compounds, like allyl alcohol (acti-
vated by alcohol dehydrogenases), that show effects only at very
high concentration in zebrafish embryos (Knöbel et al., 2012;
Klüver et al., 2014). An explanation for these differences may be
that the metabolic capabilities of fish embryos are not always sim-
ilar to that of juvenile or adult fish. Lastly, chemicals which are dif-
ficult to test in terms of solubility, volatility, sorptivity, etc. provide
the same challenges to conducting either the standard acute fish
test or the fish embryo test (Belanger et al., 2013; Knöbel et al.,
2012).
A more detailed investigation of the relationships between
acute fish toxicity and fish embryo acute toxicity (FET) data were
provided by Belanger et al. (2013). In this study, data from almost
1000 FET and 2000 acute fish toxicity studies on 150 chemicals
tested in common revealed that the FET was highly predictive of
the acute fish toxicity test. The highest quality regression relation-
ship was for 96 h acute fish toxicity data compared to 96 h fish
embryo test data:
log FET LC50 ¼ ð0:989 log Fish LC50Þ  0:195;
with n ¼ 72 chemicals; r ¼ 0:95; p < 0:001 ðLC50 in mg=LÞ:
Other permutations of the acute fish–fish embryo regressions,
for example with 48 h data included, were essentially similar
(Belanger et al., 2013). Furthermore, there appeared to be little bias
based on chemical class, solubility, octanol–water partition-
coefficient, and toxicity.
When combined with the detailed validation study described
here, it can be concluded that the ZFET is a valid method to deter-
mine acute fish toxicity. Although the recently adopted OECD TG
236 ‘‘Fish embryo acute toxicity (FET) test’’ (OECD, 2013) does
not include such a statement, the ZFET may well be used as an
alternative to the acute fish toxicity test (OECD TG 203), dependingon the regulatory framework and region. Such use may result in an
overall reduction of the numbers of juvenile and adult fish required
for aquatic acute toxicity testing. For instance, in Europe, the
testing strategy on chemical safety assessment (Predicted No Effect
Concentration derivation) in the REACH endpoint-specific
guidance on acute aquatic toxicity (ECHA, 2012) includes place-
holders for validated alternative methods and mentions the ZFET
as a possible alternative to the acute fish toxicity test provided that
it is fully validated and available as a standardised method, i.e.
OECD test guideline. This requirement is met with the now avail-
able OECD TG 236 and underpinned by the very good predictive
capacity of the ZFET. The REACH guidance document should be
updated accordingly and regulatory authorities encouraged
accepting data generated using OECD TG 236.
Moreover, the use of OECD TG 236 should be considered for
acute aquatic toxicity testing of a wide range of other chemicals
and more defined classes such as biocides, plant protection prod-
ucts, pharmaceuticals, etc. The method will be broadly applicable
for use in risk assessment of chemicals for deriving information
on acute fish toxicity. Embryo tests have already been proven
useful for effluent toxicity assessments in certain countries (e.g.
Germany). Where appropriate, the ZFET test method should now
be included into the respective regulations and associated
guidance documents.
Last but not least, for the first time in the field of ecotoxicology
an alternative test method was successfully validated and resulted
in an OECD testing guideline.
The reports of Phase 1 and Phase 2 (OECD, 2011, 2012) as well as
the detailed investigation of the relationships between acute fish
toxicity and fish embryo acute toxicity (FET) data provided by
Belanger et al. (2013) were peer-reviewed by the ECVAM
Scientific Advisory Committee (ESAC). The Draft EURL ECVAM
recommendation is now in consultation with EURL ECVAM’s
stakeholders andwill undergo public consultation in 2014. The final
EURL ECVAM recommendation will be available on the IHCP web-
site: http://ihcp.jrc.ec.europa.eu/our_labs/eurl-ecvam/eurl-ecvam-
recommendations.Disclaimer
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